191 related articles for article (PubMed ID: 27609595)
1. Predictors of mortality among HIV-infected children receiving highly active antiretroviral therapy.
Njom Nlend AE; Loussikila AB
Med Mal Infect; 2017 Feb; 47(1):32-37. PubMed ID: 27609595
[TBL] [Abstract][Full Text] [Related]
2. Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia.
Ebissa G; Deyessa N; Biadgilign S
AIDS Care; 2015; 27(6):723-30. PubMed ID: 25599414
[TBL] [Abstract][Full Text] [Related]
3. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
[TBL] [Abstract][Full Text] [Related]
4. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.
Puthanakit T; Aurpibul L; Oberdorfer P; Akarathum N; Kanjananit S; Wannarit P; Sirisanthana T; Sirisanthana V
Clin Infect Dis; 2007 Feb; 44(4):599-604. PubMed ID: 17243067
[TBL] [Abstract][Full Text] [Related]
5. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort.
Wamalwa DC; Obimbo EM; Farquhar C; Richardson BA; Mbori-Ngacha DA; Inwani I; Benki-Nugent S; John-Stewart G
BMC Pediatr; 2010 May; 10():33. PubMed ID: 20482796
[TBL] [Abstract][Full Text] [Related]
6. Impact of highly active antiretroviral therapy on nutritional and immunologic status in HIV-infected children in the low-income country of Ethiopia.
Ebissa G; Deyessa N; Biadgilign S
Nutrition; 2016 Jun; 32(6):667-73. PubMed ID: 26875999
[TBL] [Abstract][Full Text] [Related]
7. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
8. Mortality and its predictors among highly active antiretroviral therapy naive hiv-infected individuals: data from prospective cohort study in Ukraine.
Zhyvytsia D
Georgian Med News; 2014; (232-233):69-74. PubMed ID: 25214276
[TBL] [Abstract][Full Text] [Related]
9. Predicting mortality in HIV-infected children initiating highly active antiretroviral therapy in a resource-deprived setting.
Nugent J; Edmonds A; Lusiama J; Thompson D; Behets F;
Pediatr Infect Dis J; 2014 Nov; 33(11):1148-55. PubMed ID: 24945879
[TBL] [Abstract][Full Text] [Related]
10. The impact of malnutrition in survival of HIV infected children after initiation of antiretroviral treatment (ART).
Taye B; Shiferaw S; Enquselassie F
Ethiop Med J; 2010 Jan; 48(1):1-10. PubMed ID: 20607992
[TBL] [Abstract][Full Text] [Related]
11. Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India.
Banerjee T; Pensi T; Banerjee D; Grover G
Ann Trop Paediatr; 2010; 30(1):27-37. PubMed ID: 20196931
[TBL] [Abstract][Full Text] [Related]
12. Risk of first-line antiretroviral therapy failure in HIV-infected Thai children and adolescents.
Bunupuradah T; Sricharoenchai S; Hansudewechakul R; Klinbuayaem V; Teeraananchai S; Wittawatmongkol O; Akarathum N; Prasithsirikul W; Ananworanich J;
Pediatr Infect Dis J; 2015 Mar; 34(3):e58-62. PubMed ID: 25478649
[TBL] [Abstract][Full Text] [Related]
13. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
Viani RM; Araneta MR; Deville JG; Spector SA
Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
[TBL] [Abstract][Full Text] [Related]
14. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
[TBL] [Abstract][Full Text] [Related]
15. Predictors of mortality among HIV infected children on anti-retroviral therapy in Mekelle Hospital, Northern Ethiopia: a retrospective cohort study.
Gebremedhin A; Gebremariam S; Haile F; Weldearegawi B; Decotelli C
BMC Public Health; 2013 Nov; 13():1047. PubMed ID: 24517533
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
[TBL] [Abstract][Full Text] [Related]
17. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
[TBL] [Abstract][Full Text] [Related]
18. Morbidity and mortality in HIV-infected children on antiretroviral therapy in Togo.
Mouhari-Touré A; Mahamadou G; Kombate K; Akakpo AS; Teclessou JN; Singo A; Pitché P
Med Sante Trop; 2018 Feb; 28(1):54-60. PubMed ID: 29616646
[TBL] [Abstract][Full Text] [Related]
19. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort.
Gutierrez F; Padilla S; Masiá M; Iribarren JA; Moreno S; Viciana P; Muñoz L; Gómez Sirvent JL; Vidal F; López-Aldeguer J; Blanco JR; Leal M; Rodríguez-Arenas MA; Perez Hoyos S;
PLoS One; 2006 Dec; 1(1):e89. PubMed ID: 17183720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
